Physician

Mahmud S. Khan, MD

According to 2025 Medicare claims, Mahmud Khan, MD (NPI: 1952331464) practices nephrology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1821159021; TIN: 23-2730785) and primary practice location at 17325-7878. Khan is affiliated with the Keystone ACO (ACO ID: A1552) and WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 972 HCPCS/CPT codes, and received $73,206 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 875 prescription claims across 282 beneficiaries totaling $111,399 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 48 claims. Open Payments data shows 1 records totaling $3. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $259,965 to $73,206. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $297,839 and ending at $111,399. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,405 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$134K$268K2015 Medicare payment: $259,965 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $267,707 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $230,528 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $93,744 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $101,960 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $92,605 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $77,880 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $84,497 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $69,374 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $73,206 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155263,021$259,965
20165562,609$267,707
20174512,199$230,528
20184301,251$93,744
20194741,274$101,960
20204041,209$92,605
2021318966$77,880
2022358951$84,497
2023279706$69,374
2024338972$73,206

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$181K$362K2015 Drug cost: $297,839 (USD; Tot_Drug_Cst)2016 Drug cost: $272,075 (USD; Tot_Drug_Cst)2017 Drug cost: $362,014 (USD; Tot_Drug_Cst)2018 Drug cost: $64,494 (USD; Tot_Drug_Cst)2019 Drug cost: $54,421 (USD; Tot_Drug_Cst)2020 Drug cost: $42,222 (USD; Tot_Drug_Cst)2021 Drug cost: $68,211 (USD; Tot_Drug_Cst)2022 Drug cost: $95,915 (USD; Tot_Drug_Cst)2023 Drug cost: $135,725 (USD; Tot_Drug_Cst)2024 Drug cost: $111,399 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151722,068$297,839
20162031,445$272,075
20171691,085$362,014
20182981,350$64,494
20192851,454$54,421
20202491,101$42,222
2021216898$68,211
20222331,052$95,915
20232771,220$135,725
2024282875$111,399

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.4K$11K2015 Medicare payment: $4,866 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $10,819 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $5,243 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $6,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $9,336 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $7,239 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,031 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,279 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $742 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R135$4,866
201638292$10,819
2017N/R152$5,243
201830218$6,539
201964304$9,336
202023224$7,239
202126137$3,031
2022N/R71$1,279
2023N/R48$742
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more121121$121
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes5255$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more76116$94
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes110235$60
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's122199$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin523,781$69,588
ClinolipidFat Emulsion/Olive/Soy/Phospho18126$5,721
Potassium Citrate ErPotassium Citrate221,650$1,665
ChlorthalidoneChlorthalidone866,840$1,348
Potassium ChloridePotassium Chloride351,440$1,264

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$3Travere Therapeutics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mahmud S. Khan, MD?

Tedicare shows public-source Medicare data for Mahmud S. Khan, MD (NPI 1952331464), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mahmud S. Khan, MD have ACO affiliation data?

Mahmud S. Khan, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Mahmud S. Khan, MD?

Mahmud S. Khan, MD is linked to WELLSPAN MEDICAL GROUP (billing NPI 1821159021) in the available physician profile data.

Does Mahmud S. Khan, MD have Open Payments data?

Mahmud S. Khan, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.